Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024 – Biotech Investments
New York, 05/16/2024 / 09:00, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Laxxon Medical, a
New York, 05/16/2024 / 09:00, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Laxxon Medical, a
On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on
SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians alike are fed up. Overdose death rates remain near all-time
SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?
SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could
WASHINGTON — A House subcommittee on Thursday advanced legislation that would extend some pandemic-era telehealth policies in Medicare for two years, bringing the panel’s approach
What You Should Know: – Saint Luke’s Mid America Heart Institute today launched the newest solution on its care platform, a comprehensive program to support
What You Should Know: – Daffodil Health, a healthcare technology company, has secured $4.6M in seed funding to tackle the multi-billion dollar problem of wasted
What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5
Dexcom shared more details about its plans to sell an over-the-counter continuous glucose monitor this summer. The device, called Stelo, is intended for people with